Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection
Top Cited Papers
Open Access
- 9 November 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (11), e0240784
- https://doi.org/10.1371/journal.pone.0240784
Abstract
Fatigue is a common symptom in those presenting with symptomatic COVID-19 infection. However, it is unknown if COVID-19 results in persistent fatigue in those recovered from acute infection. We examined the prevalence of fatigue in individuals recovered from the acute phase of COVID-19 illness using the Chalder Fatigue Score (CFQ-11). We further examined potential predictors of fatigue following COVID-19 infection, evaluating indicators of COVID-19 severity, markers of peripheral immune activation and circulating pro-inflammatory cytokines. Of 128 participants (49.5 ± 15 years; 54% female), more than half reported persistent fatigue (67/128; 52.3%) at median of 10 weeks after initial COVID-19 symptoms. There was no association between COVID-19 severity (need for inpatient admission, supplemental oxygen or critical care) and fatigue following COVID-19. Additionally, there was no association between routine laboratory markers of inflammation and cell turnover (leukocyte, neutrophil or lymphocyte counts, neutrophil-to-lymphocyte ratio, lactate dehydrogenase, C-reactive protein) or pro-inflammatory molecules (IL-6 or sCD25) and fatigue post COVID-19. Female gender and those with a pre-existing diagnosis of depression/anxiety were over-represented in those with fatigue. Our findings demonstrate a significant burden of post-viral fatigue in individuals with previous SARS-CoV-2 infection after the acute phase of COVID-19 illness. This study highlights the importance of assessing those recovering from COVID-19 for symptoms of severe fatigue, irrespective of severity of initial illness, and may identify a group worthy of further study and early intervention.Keywords
Funding Information
- Wellcome Trust (203930/B/16/Z)
- Health Research Board (203930/B/16/Z)
This publication has 69 references indexed in Scilit:
- Chronic fatigue syndrome, the immune system and viral infectionBrain, Behavior, and Immunity, 2012
- Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled studyBMC Neurology, 2011
- Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trialThe Lancet, 2011
- Return to work following sickness absence due to infectious mononucleosisOccupational Medicine, 2010
- Fatigue, Function, and Mortality in Older AdultsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- The impact of energy modulation on physical functioning and fatigue severity among patients with ME/CFSPatient Education and Counseling, 2009
- Chronic Fatigue Syndrome After Infectious Mononucleosis in AdolescentsPEDIATRICS, 2009
- Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort studyBMJ, 2006
- Evidence for the Presence of Immune Dysfunction in Chronic Fatigue SyndromeClinical and Vaccine Immunology, 2002
- Development of a fatigue scaleJournal of Psychosomatic Research, 1993